Work

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

Year: 2009

Type: article

Source: Clinical Lymphoma & Myeloma

DOI: 10.3816/clm.2009.n.082

Authors: Madeleine Duvic, Elise A. Olsen, Debra Breneman, Theresa R. Pacheco, Sareeta Parker, Eric C. Vonderheid, Rachel Abuav, Justin L. Ricker, Syed Rizvi, Cong Chen, Kathleen Boileau, Alexandra Gunchenko, Cesar Sanz-Rodriguez, Larisa J. Geskin

Institutions: The University of Texas MD Anderson Cancer Center, Duke University, University of Cincinnati, University of Cincinnati Medical Center, University of Colorado Health, Emory University, Johns Hopkins University, Johns Hopkins Medicine, Merck & Co., Inc., Rahway, NJ, USA (United States), Merck, S.L.U. (Spain), University of Pittsburgh

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976261196

FWCI: 6.26

Cites: 38

Cited by: 98

Related to: 10